MoineauWorld.com – Where Cooking Meets Tech & Everything Between

Tag: durability

Psilocybin Breakthrough: COMP360 Nears | Analysis by Brian Moineau

Posted on by Brian Moineau

A potential first: COMP360 and the promise of a psilocybin medicine for severe depression

The headline landed with the particular mix of hope and caution that defines much of modern psychedelics reporting: Compass Pathways says its psilocybin candidate, COMP360, produced meaningful improvements for people with treatment‑resistant depression in two Phase 3 trials. If regulators agree, COMP360 could become the first approved psilocybin‑based medicine — and only the second psychedelic‑derived drug after Johnson & Johnson’s Spravato. That’s a big deal, but it’s also the start of another complicated conversation about efficacy, safety, access, and what “success” really means for people who have run out of options.

What matters most right now

  • Compass announced two positive Phase 3 readouts showing statistically significant improvements on the MADRS depression scale at Week 6. (statnews.com)
  • The trials show a rapid onset of effect (some patients reporting improvement by the day after dosing) and some durability through later follow‑up in at least one study arm. (ir.compasspathways.com)
  • Compass has requested an FDA meeting and intends to pursue a rolling NDA submission, targeting completion of the filing later in the year. (ir.compasspathways.com)

A little background that frames the excitement

  • Treatment‑resistant depression (TRD) generally means a patient hasn’t responded to two or more antidepressant treatments. TRD is common, debilitating, and costly — clinically and personally. Novel approaches that deliver rapid relief would be transformative.
  • COMP360 is a synthetic, proprietary formulation of psilocybin administered in a controlled, therapeutic context (dosing sessions plus psychological support). Compass has been running two parallel Phase 3 trials: COMP005 (single‑dose design) and COMP006 (two doses three weeks apart). (ir.compasspathways.com)
  • This program builds on prior Phase 2 work and growing evidence that classic psychedelics, paired with therapy, can produce meaningful changes in mood and cognition for some patients. But psychedelics aren’t a universal fix — and clinical trials face unique blinding and placebo challenges. (theguardian.com)

Reading the results with sensible optimism

What Compass reported is encouraging but not unequivocal. Here are the key technical points that shape how to interpret the news:

  • Statistically significant but modest mean differences: The primary endpoint in the most recent trial showed a mean MADRS difference of about -3.8 points (25 mg vs 1 mg) at Week 6 — statistically significant, and described by Compass as “clinically meaningful.” Context matters: group mean differences in depression trials can underestimate benefit for individual responders, but regulators weigh both average effect and responder/remission rates. (ir.compasspathways.com)
  • Rapid effects: Multiple reports emphasize a fast onset — some patients reporting improvement by the day after dosing — which is distinct from conventional antidepressants that typically take weeks. Rapid relief can be especially important in severe, suicidal, or highly incapacitating depression. (ir.compasspathways.com)
  • Durability and retreatment: Compass reported durability through Week 26 for many participants in COMP005 and suggested that a second dose helped some people who had not fully remitted by six weeks. Durability of benefit without frequent repeat dosing will be crucial for adoption and payer decisions. (ir.compasspathways.com)
  • Safety profile: Compass reports no unexpected safety findings and that adverse events were generally mild to moderate and transient. Still, the psychedelics space must remain alert to rare but serious psychiatric adverse events and to the challenges of scaling therapy‑intensive treatments safely. (ir.compasspathways.com)

How regulators and clinicians will look at this

  • Regulators want both robust statistical evidence and clinically meaningful benefits for patients. The FDA will review full datasets, not headlines — that includes remission and responder rates, subgroup analyses, safety signals, durability, and real‑world feasibility considerations. Compass has asked for a meeting and is planning a rolling NDA submission. (ir.compasspathways.com)
  • Clinicians and payers will ask: who benefits most? How durable is the effect? How many supervised sessions and trained therapists are required? What are the risks in real‑world settings? Answers to those questions will determine whether COMP360 becomes a narrowly used specialty treatment or a broadly accessible option. (statnews.com)

The access and implementation puzzle

Even if COMP360 wins approval, substantial obstacles remain before many patients benefit:

  • Delivery model: Psilocybin treatment, as tested, pairs drug administration with extended therapeutic support. That requires trained facilitators, clinic space, monitoring, and billing pathways — all of which add cost and complexity.
  • Workforce and training: There’s a practical shortage of clinicians trained to deliver psychedelic‑assisted therapy at scale. Building that workforce will take time, standardized curricula, and possibly new professional roles.
  • Cost and coverage: Payers will weigh the drug cost plus therapy sessions against clinical benefit and alternative treatments (including Spravato and standard antidepressants). Demonstrating durable remission and reduced overall health costs will strengthen the case for coverage.
  • Equity concerns: If early access remains primarily private or clinic‑based, underserved patients may be left behind, worsening disparities in mental‑health care. (washingtonpost.com)

Where COMP360 fits in the broader psychedelic landscape

  • COMP360 could be the first approved classic psilocybin medicine, which would be a regulatory milestone and likely accelerate investment and research across the field. But one approval doesn’t settle debates about indications, dosing strategies, or the therapeutic model. (statnews.com)
  • Other psychedelics (ketamine derivatives like Spravato, MDMA for PTSD, DMT trials) are advancing along parallel tracks. Each compound has a different pharmacology, therapeutic profile, and logistical footprint — meaning multiple psychedelic options could coexist, each suited to distinct patients and settings. (theguardian.com)

My take

This is a meaningful step. The consistency of two positive Phase 3 readouts moves COMP360 from hopeful experiment toward a plausible treatment option. The truly consequential questions now aren’t just whether regulators will approve COMP360, but who will be able to access it, how durable its benefits are in routine care, and whether health systems can deliver it safely and equitably. Hype is easy; the hard work is operationalizing evidence into care that reaches the people who need it most.

What to watch next

  • The FDA meeting and the timing/details of Compass’s NDA rolling submission. (ir.compasspathways.com)
  • Full trial publications or datasets showing remission and responder rates, subgroup analyses (e.g., by severity, comorbidity), and safety details beyond Week 6. (statnews.com)
  • Real‑world pilots and payer decisions that will reveal how accessible and sustainable psilocybin therapy can be outside trials.

Sources

Final note: these developments are unfolding quickly. The next weeks — regulatory meetings, full data disclosures, and peer‑reviewed publications — will be the best place to revisit whether COMP360’s promise holds up in the detailed numbers and in real‑world practice.

Double Your Switch 2 Storage Cheaply | Analysis by Brian Moineau

Posted on by Brian Moineau

Hook: Double your Switch 2 storage without breaking the bank

If you picked up a Nintendo Switch 2 and already feel the squeeze of downloads and day-one patches, there’s a refreshingly affordable fix: Samsung’s new P9 microSD Express cards are on sale, and the discounts make them an excellent way to more than double your console’s storage for a very reasonable price. This feels like the kind of upgrade every Switch 2 owner will appreciate — fast, future-ready, and finally affordable.

Why this matters right now

  • The Switch 2 ships with a finite amount of internal storage, and big third‑party titles or lots of downloadable content can fill it quickly.
  • Nintendo embraced the newer microSD Express standard for the Switch 2 to allow much faster external storage performance than the original Switch’s UHS‑I microSD cards.
  • Samsung’s P9 cards are built specifically for microSD Express devices (with sequential read speeds up to 800 MB/s), so they’re designed to give the Switch 2 snappy load times and quicker installs compared with older cards. (semiconductor.samsung.com)

The deal (what The Verge reported)

  • Samsung’s P9 microSD Express 256GB model has been discounted — the price starts at roughly $39.99 after a $15 reduction, making it a very affordable way to double some Switch 2 configurations’ available space. The 512GB model was also discounted (about $79.99 after a $40 reduction), which is close to its best price on record. These sale prices were highlighted in coverage of holiday/Cyber Monday promotions. (theverge.com)

How the P9 compares to older microSD options

  • Speed: The P9’s PCIe-based microSD Express performance (reported up to 800 MB/s sequential reads) is several times faster than typical UHS‑I cards used with the original Switch. That helps with game installs, patch downloads and asset streaming. (tech.yahoo.com)
  • Compatibility: Samsung notes the P9 is compatible with Switch 2 and also backward compatible with devices using UHS‑I slots — though on older devices speeds will be limited by the host. (semiconductor.samsung.com)
  • Durability and warranty: Samsung advertises 6-proof protection (water, temperature, X-ray, magnet, drop, wear) and a limited warranty for the P9 line, which is reassuring for users who carry cards between devices or travel with their handheld. (samsung.com)

Who should buy one (and who might wait)

  • Great fit:
    • Switch 2 owners who primarily buy digital games and want to avoid juggling installs.
    • Gamers who want faster load times and a future‑proof card that won’t bottleneck the console.
    • Anyone who likes having a dedicated card for console libraries and backups.
  • Maybe wait:
    • Users who rarely buy digital games and prefer physical cartridges.
    • People who already own a very large (1TB+) microSD Express card or who don’t need the additional speed.
    • Buyers who can wait for deeper discounts (sales often return around major shopping events).

Price perspective

  • A cheap 256GB P9 at around $40 is compelling because it effectively doubles storage for many Switch 2 configurations at a modest cost.
  • The 512GB SKU at roughly $80 gives you more breathing room for an entire digital library and sits near the card’s historic low — if you want to avoid swapping cards frequently, the 512GB is worth the extra outlay. Pricing can fluctuate across retailers, so it’s worth checking multiple stores if you’re hunting for the lowest price. (theverge.com)

Practical tips for buyers

  • Confirm your console: The Switch 2 specifically supports microSD Express — older Switch microSD cards won’t get that full performance boost on the new hardware.
  • Think capacity by game habits: Many Nintendo-published games remain modest in size, but some third‑party AAA titles can be large; if you buy lots of big third‑party games, lean toward larger capacities.
  • Check return policies and warranties: Buy from reputable retailers and keep receipts in case you need warranty service; Samsung lists a limited warranty and 6-proof durability for the P9. (news.samsung.com)

My take

This sale rounds the P9 into a genuinely practical upgrade for most Switch 2 owners. The microSD Express standard unlocks the console’s faster external storage potential, and Samsung’s price cuts make the performance accessible rather than premium-only. If you’re filling up the console or prefer to keep a large library on hand, the 256GB at about $40 is a low-friction, high-value buy — and the 512GB at roughly $80 is the sweet spot if you want to avoid juggling cards. Either way, these discounts turn an obvious accessory into a must-have.

Sources



Related update: We recently published an article that expands on this topic: read the latest post.

Related update: We recently published an article that expands on this topic: read the latest post.

Wilbur Wood: White Sox Ironman Legacy | Analysis by Brian Moineau

Posted on by Brian Moineau

Wilbur Wood, the White Sox Workhorse, Has Passed Away at 84

An image of a worn baseball glove and a well-traveled pitcher’s mound feels right when you think of Wilbur Wood. He wasn’t flashy. He didn’t light up radar guns. What he did was simpler — and rarer: he showed up, year after year, inning after inning, wielding a knuckleball that befuddled hitters and preserved his team’s rotation in an era when starters were expected to finish what they began. Wood died on January 17, 2026, at age 84, leaving behind a legacy built on durability, craft, and an almost old‑world approach to pitching.

Why his story matters

  • Wood belongs to a line of pitchers who redefined how teams used innings. In the early 1970s he was not merely effective — he was essential.
  • He is one of the last true ironmen in the Live Ball Era: four seasons of 300+ innings and a 1972 campaign (376 2/3 innings and 49 starts) that is largely unthinkable in modern baseball.
  • His transformation from a marginal reliever to a frontline starter after committing to the knuckleball (mentored by Hoyt Wilhelm) is a neat, human story about adaptation and mentorship in sports.

A quick look back at the career

  • Began major-league life with the Boston Red Sox (debut at age 19 in 1961), had a brief stop with the Pittsburgh Pirates, then found a home in Chicago from 1967–1978.
  • After learning the knuckleball more seriously (with guidance from Hoyt Wilhelm), Wood shifted from mop-up reliever to workhorse starter.
  • Peak years were 1971–1974: multiple 20-win seasons, three All‑Star nods, and top finishes in Cy Young voting.
  • Career totals include 164 wins, a 3.24 ERA, 2,684 innings pitched, and a reputation for completing games and eating innings few today would dare attempt.

What made Wilbur Wood special

  • Durability: Four seasons with 300 or more innings (1971–1974) during which he routinely started on short rest and completed games that modern starters rarely attempt.
  • The knuckleball: Wood converted a quirky, low-velocity pitch into a career-defining weapon. That pitch allowed him to pitch deep into games and seasons when conventional wisdom favored burnouts from heavy workload.
  • Consistency under an old-school grind: In an era of increasingly specialized bullpens, Wood’s output was a reminder of how different roster construction and pitcher usage once were.

Things that stand out about the 1972 season

  • 376 2/3 innings pitched — the most by a starter in the Live Ball Era — and 49 starts, figures almost impossible to conceive of in baseball’s modern era.
  • Second in Cy Young voting that year, with a sub-2.60 ERA over the stretch of his dominance.
  • Those totals are anchor points for conversations about pitcher health, modern workload limits, and how the game has evolved since the 1970s.

A player shaped by place and mentors

  • Wood’s Massachusetts roots and his early call-up at 19 hint at a long relationship with the game that required reinvention to survive.
  • The role of veterans like Hoyt Wilhelm in refining his knuckleball underscores the often-understated value of mentorship — a coaching moment that turned a career around.
  • After baseball, Wood returned to private life and business pursuits, reflective of a generation of players who didn’t always remain in the spotlight after retirement.

Remembering the human side

It’s easy to reduce a figure like Wood to innings, starts, and WAR. The fuller picture includes grit, the humility of a craft pitcher, and the laugh in the clubhouse when the knuckleball danced across the plate. Tributes from teammates, the White Sox organization, and fans highlight a player who was admired not just for numbers but for how he embodied reliability — the most underrated currency in team sports.

Final thoughts

Wilbur Wood’s story is both a relic and a lesson. It’s a relic because the baseball landscape that produced 300‑inning seasons no longer exists. It’s a lesson because his career shows how skill reinvention, mentorship, and toughness can carve out a long, meaningful run even when raw physical tools aren’t elite. As baseball keeps changing — with limiting innings, protecting arms, and using analytics to rethink roles — remembering figures like Wood helps preserve a sense of continuity and respect for craft. He wasn’t a Hall-of-Famer by plaque, but he was a Hall‑of‑Character in the hearts of White Sox fans and plenty of baseball purists.

Remembering him through the numbers and the moments

  • 17 major-league seasons (1961–1978).
  • 164 career wins, 3.24 ERA, 2,684 innings pitched.
  • Three-time All-Star; multiple top finishes in Cy Young voting.
  • Signature seasons from 1971–1974 that defined him as one of the most durable starters of his era.

Sources



Related update: We recently published an article that expands on this topic: read the latest post.

Related update: We recently published an article that expands on this topic: read the latest post.

Bland’s Foot Injury Threatens Cowboys Run | Analysis by Brian Moineau

Posted on by Brian Moineau

When a Season Tilts: DaRon Bland, the Cowboys’ Corner, and the Fragility of Momentum

A gut-punch moment for Cowboys fans: DaRon Bland — the All-Pro corner who altered games with his ball-hawking instincts — is now a realistic injured‑reserve candidate because of a foot issue that surfaced during preparations for the Week 16 matchup against the Los Angeles Chargers. That single sentence carries ripple effects for Dallas’s defense, roster decisions and the feel of the locker room the rest of the way.

Quick hits you should know

  • DaRon Bland was added to the Cowboys’ practice/injury reports Dec. 18, 2025, after a foot problem that sidelined him during midweek practice and made him unlikely to play Sunday versus the Chargers. (dallascowboys.com)
  • The team signaled the injury could be serious enough to require placing Bland on season‑ending injured reserve, which would end his 2025 campaign with three games remaining. (dallascowboys.com)
  • Bland’s availability has been a recurring storyline since 2024, when a foot stress fracture forced him to miss significant time; durability is becoming a concern for a player on a big contract and with All‑Pro pedigree. (dallasnews.com)

The context: why this matters beyond one roster move

Bland is not just “a corner” for the Cowboys — he’s a playmaker with a history of flipping field position and generating turnovers. In 2023 he exploded onto the national radar, leading the league with nine interceptions and returning an unprecedented five for touchdowns. The Cowboys leaned on that playmaking ability as a cornerstone of their secondary identity.

When a player like Bland becomes unavailable late in the season, several things happen at once:

  • Opposing offenses adjust, targeting the side away from the team’s most disruptive defender. That can force the Cowboys to rotate coverages more or rely on less‑proven teammates.
  • The coaching staff suddenly faces pressure to retool matchups and potentially increase Trevon Diggs’ snaps (if/when he’s available), or to accelerate the development of younger corners. Reports indicate the Cowboys were already juggling Diggs’ status and other cornerback windows. (dallascowboys.com)
  • The front office and medical staff must balance short‑term competitiveness against long‑term health. Putting Bland on IR could protect his recovery and the team’s future investment, but it also concedes immediate defensive continuity.

What the roster implications look like

  • If Bland lands on injured reserve: Dallas must hollow out a starting-caliber role across the secondary for the remaining three games, or shuffle Diggs and backups into heavier duty. The team has options — returning players from the practice squad window, flipping nickel personnel, or leaning on coverage schematics that mask inexperience — but none are perfect substitutes for an All‑Pro. (dallascowboys.com)
  • If Bland avoids IR and misses only a few games: the Cowboys preserve a matchup advantage for the playoffs (in a healthy scenario), but risk aggravating the injury and possible surgery/longer absence later. Given Bland’s recent foot history, conservative management is a rational path. (dallasnews.com)

What this means for the Chargers game — and the rest of the month

Even if Bland is inactive Sunday, the Cowboys can still defend well on schematic strength and pass rush. Still, his absence compresses margin for error: coverages that rely on tight single‑coverage outside could be more vulnerable, and Dallas may have to trust inexperienced alignments in crucial moments.

For the Chargers game specifically, expect the Cowboys to:

  • Mix zone and help over the top to keep receivers away from the sideline where young corners can get isolated.
  • Increase safety rotation and safety‑to‑slot matchups to account for mismatches.
  • Consider elevating practice‑squad or depth corners to provide fresh legs and special‑teams value.

My take

It’s disappointing on a human level — no player wants to see a season end in a quiet medical room rather than the bright lights of a game. For the Cowboys, this moment reveals two hard truths: elite playmakers are also fragile, and a good roster is built not only with stars but with dependable depth plans. I’d rather see the team make the prudent medical call even if it costs the next three games. Protecting Bland’s long‑term health preserves the investment and gives Dallas a chance to start 2026 with one of its best defenders healthy.

Final thoughts

Injuries are the cruel equalizer of the NFL. The way Dallas responds — schematically and in roster moves — will show whether the organization learned from past seasons about building sustainable depth. Fans should brace for a few imperfect weeks, but also remember that smart, measured decisions now could be the difference between a recovered All‑Pro next fall and a chronic problem that lingers beyond one campaign.

Sources



Related update: We recently published an article that expands on this topic: read the latest post.

Related update: We recently published an article that expands on this topic: read the latest post.

iPhone Fold: Five Game-Changing Features | Analysis by Brian Moineau

Posted on by Brian Moineau

Get Ready for the iPhone Fold: Five Exciting Features Set to Launch

Are you ready to embrace the future of smartphones? Rumors are swirling, and anticipation is building as Apple gears up to unveil its first foldable iPhone next year. If you thought the traditional smartphone design was the pinnacle of innovation, wait until you see what the iPhone Fold has in store. In this blog post, we’ll dive into the five new features that promise to redefine how we interact with our devices.

The Rise of Foldable Smartphones

The foldable smartphone market has been heating up in recent years, with competitors like Samsung and Huawei already making waves with their offerings. Apple, known for its innovation and customer-centric design, has held out—until now. The tech giant has finally decided to join the foldable revolution, and the excitement surrounding the iPhone Fold is palpable. But what exactly can we expect from this new device?

Five New Features of the iPhone Fold

1. Flexible Display Technology: At the heart of the iPhone Fold is its flexible display, allowing for a seamless transition between a compact phone and a larger tablet-like experience. This technology enhances user interaction, making multitasking and media consumption a breeze.

2. Enhanced Multitasking Capabilities: With the larger screen real estate, Apple is rumored to introduce advanced multitasking features. Users may be able to run multiple apps side by side, transforming how we use our phones for both work and leisure.

3. Improved Camera Systems: The iPhone Fold is expected to come with cutting-edge camera technology. Rumors suggest it could feature an innovative setup that takes advantage of the foldable design, potentially allowing for new photography angles and improved low-light performance.

4. Robust Durability: Apple is known for its premium build quality, and the iPhone Fold will reportedly follow suit. Expect a durable design that can withstand the rigors of daily use, including advanced hinges and materials that resist scratches and dents.

5. iOS Optimizations: With the introduction of the iPhone Fold, Apple will likely optimize iOS for a foldable experience. This could mean new gestures, apps designed specifically for the foldable format, and enhanced integration with other Apple devices.

Key Takeaways

- Foldable Design: The iPhone Fold will feature a flexible display that converts between phone and tablet modes. - Advanced Multitasking: Expect improved multitasking capabilities that allow users to run multiple apps simultaneously. - Camera Innovations: An upgraded camera system tailored to the foldable design could enhance photography experiences. - Durable Build: Apple aims to deliver a robust and long-lasting device, addressing concerns about foldable technology. - Optimized iOS: iOS will receive updates specifically designed to enhance the foldable user experience.

A New Era for Apple and Smartphone Users

As we look forward to the release of the iPhone Fold, it's clear that Apple is set to make a significant impact in the foldable smartphone market. With innovative features and a commitment to quality, the iPhone Fold could redefine our expectations for mobile technology. Whether you’re a dedicated Apple user or simply curious about the latest tech trends, this new device is bound to spark excitement and intrigue.

Stay tuned for more updates as we approach the launch date. The future of smartphones is just around the corner, and it looks foldable!

Sources

- "iPhone Fold is coming: Five new features for next year’s launch" - 9to5Mac - "The Future of Foldable Phones" - TechRadar (https://www.techradar.com/news/the-future-of-foldable-phones) - "Apple's Foldable Phone Plans" - MacRumors (https://www.macrumors.com/2023/01/15/apple-foldable-phone-rumors/)

By keeping an eye on these developments, you’ll be well-prepared to make the most of this exciting evolution in smartphone technology.